View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Syngene|19 November 2021

Chemical Development

Syngene provides comprehensive process research and development services as well as current good manufacturing practices (cGMP) manufacturing capacities to help clients with investigational to commercial-scale development programs.

Syngene’s development capabilities include advancing highly potent active pharmaceutical ingredients (HPAPI) and oligonucleotides with therapeutic and diagnostic applications, from laboratory to manufacturing scale. Our expertise also includes working with performance chemicals and specialty materials using synthetic organic chemistry and polymer chemistry.

We are proficient in developing robust chemical processes, and can scale-up a product of interest rapidly. We integrate analytical services such as method development, validation, transfer, and reference standard qualification throughout the development process. Our experts are also well-versed in providing necessary regulatory support for clients.

Understanding the many application areas of Hyaluronic acid in the cosmetic and pharma space, including possibilities for the future.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy